Send Inquiry

Request To Call Back

Samtica Abiraterone 250mg Tablets

Name: Samtica Abiraterone 250mg Tablets
Brand: DRUGS AND DEVICES PHARMA PRIVATE LIMITED
Price: 22770.0 INR
Availability: InStock

Price 22770.0 INR/ Bottle

Get a Price/Quote

MOQ : 1 Box

Samtica Abiraterone 250mg Tablets Specification

Indication
Metastatic prostate cancer

Life Span
24 months

Origin of Medicine
India

Salt Composition
Abiraterone Acetate

Dosage Form
Oral tablet

Packaging Type
Box

Brand Name
Abiratas

Pacakaging (Quantity Per Box)
120 tablets

Drug Type
Antineoplastic

Ingredients
Abiraterone Acetate

Physical Form
Tablet

Function
Anti-cancer treatment

Recommended For
Prostate Cancer Patients

Dosage
250 mg per tablet

Dosage Guidelines
As directed by physician

Suitable For
Adults

Quantity
120 Tablets

Storage Instructions
Store below 30C, dry place

Strength Category
250 mg

IP Grade
Yes

Manufactured by
Intas Pharmaceuticals

Tablet Color
White

Language
English & Hindi

Application
Hospital supply

Prescription
Required

Route
Oral

Samtica Abiraterone 250mg Tablets Trade Information

Minimum Order Quantity
1 Box

Supply Ability
500 Boxes Per Month

Delivery Time
7 Days

Samtica Abiraterone 250mg Tablets About

Introducing Samtica Abiraterone 250mg Tablets by Intas Pharmaceuticals - the virtuoso solution for metastatic prostate cancer. Crafted with IP Grade standards and the finest quality Abiraterone Acetate, these oral tablets promise a crackerjack performance in cancer care. Each box contains 120 white tablets, ensuring an affordable, unbeatable price with a special rate for hospital supply and large-scale purchases. Abiratas is suitable for adults and intended for prescription use. Store below 30C in a dry place. Exclusively exported, manufactured, and supplied from India.

Advanced Application & Key Advantages

Samtica Abiraterone 250mg Tablets are administered orally, making them convenient for patients. They are primarily used as an antineoplastic agent for adults diagnosed with metastatic prostate cancer. As the finest choice, these tablets offer the advantage of affordability, rigorous IP Grade standards, and precision pharmaceutical formulation, ensuring both efficacy and safety for hospital supply.

Packaging, Domestic Market, and Freight Details

Dispatched directly from India, Samtica Abiraterone 250mg Tablets are available at the lowest price for bulk hospital procurement. Each box contains 120 tablets and is carefully packaged to maintain quality during transit. Our prompt dispatching process ensures reliable delivery via FOB ports to the main domestic markets, guaranteeing swift and safe freight handling for every consignment.

FAQ's of Samtica Abiraterone 250mg Tablets:

Q: How should Samtica Abiraterone 250mg Tablets be administered?

A: Samtica Abiraterone 250mg Tablets should be taken orally as directed by your physician. Always follow the prescribed dosage and guidelines for optimal results.

Q: What is the primary use of Samtica Abiraterone 250mg Tablets?

A: These tablets are used primarily as an anti-cancer treatment for adults with metastatic prostate cancer, helping to inhibit cancer progression.

Q: When will I receive my order after dispatching?

A: Orders are promptly dispatched after purchase, and delivery times depend on the destination and chosen freight options. FOB port handling ensures efficient shipping across India and abroad.

Q: Where are Samtica Abiraterone 250mg Tablets manufactured, and by whom?

A: Samtica Abiraterone 250mg Tablets are manufactured by Intas Pharmaceuticals in India, ensuring strict quality standards.

Q: What are the main competitive advantages of Samtica Abiraterone 250mg Tablets?

A: Key advantages include crackerjack efficacy, affordable pricing, compliance with IP Grade standards, and precise formulation for hospital supply.

Q: How should the tablets be stored to maintain efficacy?

A: Store the tablets below 30C in a dry place, away from direct sunlight and moisture, to preserve their effectiveness over the 24-month shelf life.

Tell us about your requirement

Price:

Quantity

Select Unit

50
100
200
250
500
1000+

Additional detail

Mobile number

More Products in ANTI-CANCER TABLETS Category

Abiraterone Acetate 250mg Tablets

Price 16221.0 INR / Box

Minimum Order Quantity : 1 Box

Suitable For : Adults

Life Span : 24 months

Ingredients : Abiraterone Acetate

Function : Other, Cancer care

Get a Price/Quote

Afanat 30 Mg

Price 4152.0 INR / Box

Minimum Order Quantity : 2 Boxes

Suitable For : Adults

Life Span : See package for expiry

Ingredients : Afatinib

Function : AntiCancer

Get a Price/Quote

Sonora 200 mg Tablet 30N

Price 5515.0 INR / Bottle

Minimum Order Quantity : 2 Boxes

Suitable For : Adults

Life Span : Check expiry on pack

Ingredients : Sorafenib

Function : AntiCancer

Get a Price/Quote

Daslemia 100mg Tablet

Price 3499.0 INR / Bottle

Minimum Order Quantity : 5 Pieces

Suitable For : Adults

Life Span : Check expiry on pack

Ingredients : Daslemia 100 contains Dasatinib 100 mg, a potent targeted tyrosine kinase inhibitor produced by Intas Pharmaceuticals Ltd. It is widely prescribed for the management of Philadelphia chromosomepositive (Ph+) Chronic Myeloid Leukemia (CML) and Acute Lymphoblastic Leukemia (ALL). Daslemia 100 acts by blocking targeted abnormal proteins that signal cancer cells to multiply. Manufactured in WHOGMP compliant facilities, this product offers high bioequivalence and efficacy. Available in a pack of 30 tablets for international pharma distributors, hospital procurement, and wholesale export supply. Product Features: High efficacy oral targeted therapy formulation. Formulated in compliance with international quality and manufacturing standards. Moisturesealed packaging to preserve stability and shelflife. Manufactured by Intas Pharmaceuticals, a global healthcare leader. Applications: Firstline treatment for adults with newly diagnosed chronic phase Ph+ CML. Treatment of postimatinib resistant or intolerant Ph+ CML in adult patients. Treatment of Philadelphia chromosomepositive acute lymphoblastic leukemia (Ph+ ALL). Daslemia 100 contains Dasatinib 100 mg, a potent targeted tyrosine kinase inhibitor produced by Intas Pharmaceuticals Ltd. It is widely prescribed for the management of Philadelphia chromosomepositive (Ph+) Chronic Myeloid Leukemia (CML) and Acute Lymphoblastic Leukemia (ALL). Daslemia 100 acts by blocking targeted abnormal proteins that signal cancer cells to multiply. Manufactured in WHOGMP compliant facilities, this product offers high bioequivalence and efficacy. Available in a pack of 30 tablets for international pharma distributors, hospital procurement, and wholesale export supply. Product Features: High efficacy oral targeted therapy formulation. Formulated in compliance with international quality and manufacturing standards. Moisturesealed packaging to preserve stability and shelflife. Manufactured by Intas Pharmaceuticals, a global healthcare leader. Applications: Firstline treatment for adults with newly diagnosed chronic phase Ph+ CML. Treatment of postimatinib resistant or intolerant Ph+ CML in adult patients. Treatment of Philadelphia chromosomepositive acute lymphoblastic leukemia (Ph+ ALL).

Function : Other

Get a Price/Quote